Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

  • Technology appraisal guidance
  • TA170
  • Published: 
Download guidance (PDF)

6 Recommendations for further research

6.1

Further head-to-head trials of rivaroxaban compared with enoxaparin and dabigatran in both total hip replacement and total knee replacement would be useful to strengthen the evidence base for this comparison.